নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

farmagon - mometasonfuroat - nesespray, suspensjon - 50 mikrog/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

farmagon - mometasonfuroat - nesespray, suspensjon - 50 mikrog/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - triamcinolonacetonid - nesespray, suspensjon - 55 mikrog/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

paranova as - azelastinhydroklorid / flutikasonpropionat - nesespray, suspensjon - 137 mikrog/ dose / 50 mikrog/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

intervet international bv - 5831 an - bordetella bronchiseptica, stamme bb7 92932, fimbrie - injeksjonsvæske, suspensjon i ferdigfylt sprøyte

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - azelastinhydroklorid / flutikasonpropionat - nesespray, suspensjon - 137 mikrog/ dose / 50 mikrog/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - oksytocin - nesespray, oppløsning - 6.7 mikrog/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

2care4 aps - sumatriptansuksinat - nesespray, oppløsning - 20 mg/ dose

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

2care4 aps - sumatriptansuksinat - nesespray, oppløsning - 20 mg/ dose

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratorisk syncytialvirusinfeksjoner - vaksiner - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.